Bradmer Pharmaceuticals Inc. (TSX VENTURE:BMR.H) announced today that it has
granted, subject to regulatory approval, options to directors and officers of
the company exercisable to acquire an aggregate of 1,500,000 common shares, at a
price of $0.10 per share, expiring July 21, 2021.
Bradmer Pharmaceuticals (TSXV:BMR.H)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Bradmer Pharmaceuticals Charts.
Bradmer Pharmaceuticals (TSXV:BMR.H)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Bradmer Pharmaceuticals Charts.